Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYNJ2 | O15056 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 4/20 | 0.49 |
| ▸ | CA1 | P00915 | 4/20 | 0.49 |
| ▸ | CA2 | P00918 | 4/20 | 0.49 |
| ▸ | CA7 | P43166 | 4/20 | 0.49 |
| ▸ | CA9 | Q16790 | 4/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.49 |
| ▸ | CA6 | P23280 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | POLA1 | P09884 | 1/20 | 0.44 |
| ▸ | ANTXR2 | P58335 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17944269 | 1.00 | SYNJ2 (0.56) | SYNJ2CA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL22117576 | 0.93 | POLB (0.56) | SYNJ2CA12CA1CA2CA7 | |
| SCHEMBL5603951 | 0.82 | CYP3A4 (0.54) | SYNJ2POLBKDM4EMAPTPOLA1 | |
| SCHEMBL724973 | 0.80 | SYNJ2 (0.70) | SYNJ2CA12CA1CA2CA7 | |
| SCHEMBL1771466 | 0.78 | SYNJ2 (0.46) | SYNJ2CA12CA1CA2CA7 | |
| SCHEMBL1023894 | 0.78 | CA12 (0.66) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2277663 | 0.78 | CA12 (0.66) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11645189 | 0.77 | CYP3A4 (0.52) | SYNJ2POLBKDM4EMAPTCYP3A4 | |
| SCHEMBL13286773 | 0.75 | SERPINE1 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29071843 | 0.73 | SYNJ2 (0.56) | SYNJ2CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116539901-A | Application of differential metabolite as diagnostic marker and kit | 中国医学科学院北京协和医院 | 2023-08-04 | — | — | CN | claimed |
| CN-116539901-A | Application of differential metabolite as diagnostic marker and kit | 中国医学科学院北京协和医院 | 2023-08-04 | — | — | CN | disclosed |
| CN-116539901-A | Application of differential metabolite as diagnostic marker and kit | 中国医学科学院北京协和医院 | 2023-08-04 | — | — | CN | disclosed |
| US-20220074958-A1 | METHODS OF MONITORING SAFETY OF QUERCETIN COMPOSITIONS | PUBLIC JOINT STOCK COMPANY "SCIENTIFIC INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL-PHARMACEUTICAL PLANT" (UA) | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220074958-A1 | METHODS OF MONITORING SAFETY OF QUERCETIN COMPOSITIONS | NQO2, QARS1, QPCT | SYNJ2 2456/4885CA12 1007/4885CA1 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.